Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr Lalchandani Labs Ltd held its 8th AGM on September 30, 2025, at Gulmohar Club, New Delhi, from 3:00 PM to 3:30 PM, with 10 shareholders attending including promoters. Key resolutions included adoption of FY25 financial statements, reappointment of Managing Director Arjan Lalchandani (retiring by rotation), reappointment of Whole Time Director Mohit Lalchandani for 5 years, appointment of Mohan Lal Gandhi as Independent Director for 5 years, and appointment of new secretarial auditors. A notable item was the proposal to increase the company's authorized capital from Rs. 4.5 crore to Rs. 11 crore (nearly 2.5x), along with a corresponding alteration to the capital clause of the Memorandum of Association. E-voting was conducted from September 27-29, 2025, and voting results along with the scrutinizer's report will be filed separately.
The authorized capital hike from Rs. 4.5 crore to Rs. 11 crore is the most material item, potentially enabling future fundraising, bonus issues, or stock splits, though it requires shareholder approval before any actual issuance. Director reappointments and routine business items are procedural and unlikely to move the stock on their own.